NOVARTIS AG (NVSEF)
Clinical trial NCT07549139 updates: 1. start date: 2026-06-30 → 2026-10-31 2. completion date: 2027-12-31 → 2028-04-30 3. primary completion date: 2027-12-31 → 2028-04-30
Clinical trial NCT07549139 updates: 1. start date: 2026-06-30 → 2026-10-31 2. completion date: 2027-12-31 → 2028-04-30 3. primary completion date: 2027-12-31 → 2028-04-30
Clinical trial NCT05308901 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2027-06-01 → 2025-08-11
Clinical trial NCT06198712 updates: 1. collaborators added: Novo Nordisk A/S. This study is currently undergoing a sponsor transition from Forma Therapeutics, Inc. to Novo Nordisk A/S. 2. collaborators removed: Novo Nordisk A/S
Clinical trial NCT07636811 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-31 → 2026-08-31
Clinical trial NCT07575308 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-30 → 2026-07-30
Clinical trial NCT07194980: start date: 2026-08-01 → 2026-09-01.
Clinical trial NCT07549490: start date: 2026-08-16 → 2026-08-17.
Clinical trial NCT07265479 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-01-01 → 2027-08-01 3. primary completion date: 2028-01-01 → 2027-08-01 4. enrollment: 180 → 187 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05633550 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-08-01 3. enrollment: 45 → 50 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05417594 updates: 1. completion date: 2027-11-01 → 2028-02-07 2. primary completion date: 2027-11-01 → 2028-02-07